Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Clinical trial NCT00028847 · UNKNOWN
Trial details
- NCT number
- NCT00028847
- Sponsor
- Commissie Voor Klinisch Toegepast Onderzoek
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.